Fig. 3
From: A Bayesian approach to pilot-pivotal trials for bioequivalence assessment
Probability of making correct Go or correct No-Go decision (%) towards a pivotal trial using different methods and decision frameworks to establish the average bioequivalence. The proposed method was implemented with (w, 1 - w) = (0.9, 0.1), with the ‘adjusted’ being the specification of \(\gamma\) following Eq. (7) and the ‘unadjusted’ being \(\gamma\) = 1. (a) and (b) using C\(_\text {max}\) data. (c) and (d) using AUC data